Registry-listed formulations

hesperetin · mesh:C013015

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • HesperetinRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Early Phase 1
1
100%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Early Phase 1First-in-human
1(100.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Completed(1)

Detailed Status

Completed1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (100.0%)

Trials by Status

completed1100%

Recent Activity

0 active trials
Showing 1 of 1
completedearly_phase_1

Impact of Hesperetin in Combination With Sucrose on Energy Metabolism

NCT05705596

Clinical Trials (1)

Showing 1 of 1 trials
NCT05705596Early Phase 1

Impact of Hesperetin in Combination With Sucrose on Energy Metabolism

Completed

All 1 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
1